MedTrace Logo

Lung Cancer Detection by Measuring Monocyte Activity

NCT02090166 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 950

Last updated 2014-03-18

No results posted yet for this study

Summary

Purpose: To evaluate the performance of Extracellular Monitoring of Metabolic Activity Profiles of Peripheral Blood Mononuclear Cells (PBMC) analysis method in identifying lung cancer.

The study population will include a total of 950 participants, patients with lung cancer before any treatment, and healthy and COPD patients as a control group.

Conditions

Interventions

OTHER

Blood test

a blood test will be taken from each patient

Sponsors & Collaborators

  • Tel Aviv University

    collaborator OTHER

  • Carmel Medical Center

    lead OTHER

Principal Investigators

  • Yochai Adir, MD · Carmel Medical Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2020-01-31
Completion
2021-01-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02090166 on ClinicalTrials.gov